Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetic heterogeneity and transcriptional plasticity drive resistance during immunotherapy and targeted therapy ; volume:13 ; number:1 ; day:15 ; month:1 ; year:2015 ; pages:1 ; date:12.2015
Journal of translational medicine ; 13, Heft 1 (15.1.2015), 1, 12.2015
- Urheber
-
Dummer, Reinard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-13-S1-K18
- URN
-
urn:nbn:de:1111-2016041451142
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dummer, Reinard
- SpringerLink (Online service)
Ähnliche Objekte (12)
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
BCMA-targeted immunotherapy for multiple myeloma
Signaling, cancer cell plasticity, and intratumor heterogeneity
Reversing Degraded Auditory Processing Using Targeted Plasticity
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
Transcription factors in fibroblast plasticity and CAF heterogeneity
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
BCMA-targeted immunotherapy for multiple myeloma
Signaling, cancer cell plasticity, and intratumor heterogeneity
Reversing Degraded Auditory Processing Using Targeted Plasticity
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
Transcription factors in fibroblast plasticity and CAF heterogeneity
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
BCMA-targeted immunotherapy for multiple myeloma
Signaling, cancer cell plasticity, and intratumor heterogeneity
Reversing Degraded Auditory Processing Using Targeted Plasticity
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?
Transcription factors in fibroblast plasticity and CAF heterogeneity
Targeted Therapy and Immunotherapy for Melanoma in Japan